Miles Capital’s Pediatrix Medical MD Stock Holding History

Miles Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,680	Closed	-$283K	–	211
2017 Q2	$283K	Hold	4,680	–	–	0.15%	118
2017 Q1	$325K	Buy	+4,680	New	+$325K	0.18%	98

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Miles Capital's MD Position: Q3 2017 in Review

Miles Capital sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 4,680 shares — an estimated $283K sold.

Miles Capital first reported a position in MD in Q1 2017 and held it in 2 quarters. The position peaked at $325K in Q1 2017. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

Miles Capital reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
Miles Capital sold 4,680 Pediatrix Medical shares in Q3 2017, an estimated $283K.
Miles Capital first reported a position in Pediatrix Medical in Q1 2017 and held it in 2 quarters.
Miles Capital's Pediatrix Medical position peaked at $325K in Q1 2017.
337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Miles Capital's 13F filing for Q3 2017, filed 13 Nov 2017.